Yomiuri flags U.S. drug pricing policy risks for Japan supply
Yomiuri reports a U.S. drug pricing policy linked to President Donald Trump is raising fears Japan’s “drug-loss” problem could worsen, with medicines used overseas becoming unavailable domestically.